Results 141 to 150 of about 37,898 (281)

Efficacy and safety of vericiguat in patients with HFrEF treated with sacubitril/valsartan: results from the VICTORIA trial [PDF]

, 2021
Michele Senni, Wendimagegn Alemayehu, David Sim, Frank Edelmann, Javed Butler, Justin A. Ezekowitz, Adrian F. Hernandez, C. S. P. Lam, Christohper M. O'Connor, Burkert Pieske, Piotr Ponikowski, Lothar Roessig, A.A. Voors, Ciaran J. McMullan, Paul W. Armstrong   +14 more
openalex   +1 more source

Western Diet-Fed, Aortic-Banded Ossabaw Swine: A Preclinical Model of Cardio-Metabolic Heart Failure. [PDF]

, 2019
The development of new treatments for heart failure lack animal models that encompass the increasingly heterogeneous disease profile of this patient population.
Alex, Linda, Baines, Christopher P, Domeier, Timothy L, Edwards, Jenna C, Emter, Craig A, Ferreira-Nichols, Stephanie C, Ford, David A, Gao, Chen, Ivey, Jan R, Jones, John L, Jurrissen, Thomas J, Klutho, Paula J, Krenz, Maike, McDonald, Kerry S, Olver, T Dylan, Padilla, Jaume, Rau, Christoph, Rector, R Scott, Solaro, R John, Thorne, Pamela K, Veteto, Adam B, Wang, Yibin, Warren, Chad M   +22 more
core  

Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum. [PDF]

, 2018
AIMS: We tested the hypothesis that candesartan improves outcomes in heart failure (HF) with mid-range ejection fraction [HFmrEF; ejection fraction (EF) 40-49%].
Borlaug, Chioncel, Echocardiographic Normal Ranges Meta-Analysis of the Left Heart Collaboration, Fonarow, Koh, Lam, Lam, Lang, Lofman, Lupon, Mele, Meta-analysis Global Group in Chronic Heart Failure (MAGGIC), Nauta, Paulus, Pfeffer, Ponikowski, Rastogi, Rickenbacher, Sartipy, Solomon, Solomon, Solomon, Swedberg, Tsuji, Vedin, Yusuf   +25 more
core   +2 more sources

Novel insights in HFrEF and HFpEF: patient characteristics, remote monitoring, and management [PDF]

, 2016
Thomas F. Lüscher
openalex   +1 more source

Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists: An Analysis of DAPA-HF.

JACC. Heart failure, 2021
Li Shen, S. Kristensen, O. Bengtsson, M. Böhm, Rudolf A. de Boer, K. Docherty, S. Inzucchi, T. Katova, L. Køber, M. Kosiborod, A. Langkilde, D. Lindholm, M. Martinez, E. O’Meara, J. Nicolau, M. Petrie, P. Ponikowski, M. Sabatine, M. Schou, M. Sjöstrand, S. Solomon, P. Jhund, J. McMurray   +22 more
semanticscholar   +1 more source

Metformin in the management of patients with diabetes and advanced heart failure (HFrEF): a propensity score-matched analysis [PDF]

, 2022
Jan Beneš, Martin Kotrč, Katerina Kroupova, Peter Wohlfahrt, J. Kovář, Janka Franeková, Markéta Hegarová, Lenka Hošková, Eva Hošková, Terezie Pelikánová, Petr Jarolı́m, Josef Kautzner, Vojtěch Melenovský   +12 more
openalex   +1 more source

Sex differences in left ventricular afterload and diastolic function are independent from the aortic size. [PDF]

, 2019
学位記番号 ...
Sorimachi, Hidemi, ソリマチ, ヒデミ, 反町, 秀美   +2 more
core  

Comparative analysis of serum galanin levels in patients with coronary artery disease with and without heart failure with reduced ejection fraction and in individuals without cardiovascular diseases

Кардиоваскулярная терапия и профилактика
Aim. To study the level of the neuro-regulatory peptide galanin in pa­tients with coronary artery disease (CAD) with and without heart failu­re with reduced ejection fraction (HFrEF) in comparison with individuals without cardiovascular disease (CVD ...
Yu. S. Timofeev, A. A. Yafarova, A. F. Sheptulina, A. R. Kiselev, V. A. Metelskaya, N. I. Dubovskaya, O. M. Drapkina   +6 more
doaj   +1 more source

1028 Early response to a low- dose acubitril/valsartan (ARNI) therapy among stable symptomatic patients with HFrEF [PDF]

, 2020
Wioletta Sacharczuk, Rafał Dankowski, Artur Baszko, Anna Sowińska, Stefan Ożegowski, Andrzej Szyszka   +5 more
openalex   +1 more source

Decreased endogenous nitric oxide production in acute decompensated heart failure with a reduced ejection fraction

ESC Heart Failure
Aims Heart failure represents a substantial burden to both patients and healthcare systems worldwide. Nitric oxide (NO) dysregulation may play a key role in patients transitioning from chronic to acute heart failure with a reduced ejection fraction ...
Roman Falls, Bing H. Wang, Sara Vogrin, Christopher J. Neil   +3 more
doaj   +1 more source